Un autre traitement du coronavirus en essai clinique
/https%3A%2F%2Fwww.newswire.ca%2Fcontent%2Fdam%2Fnewswire-ca%2Flogos%2Fcnw_en_facebook_sharing_logo.png%23width%3D600%26height%3D315)
SaNOtize Obtains Health Canada Approval to Commence Phase II Trial for Potential COVID-19 Therapy
New Laboratory Tests Conducted by Utah-Based Institute for Antiviral Research Confirm SaNOtize's Nitric Oxide Releasing Solution (NORSTM) is Over 99.9% Effective Against SARS-CoV-2, the Virus that ...
Commenter cet article